NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP
SS Innovations International, Inc. SSII
10 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$42.5M
▲ 105.7% vs FY2024
EPS · FY25
$-0.06
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-46.9%
Net margin · FY25
-28.5%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 42.5M
Revenue, FY2025 · full 10-year series below
Revenue
Net income
The company lost 29 cents on every revenue dollar this year.
Per share
USD -0.06
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-46.9%
Return on equity, FY2025
ROE
Operating margin-19.3%
Net margin-28.5%
Return on assets-20.8%
Each USD of equity lost 47 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
—
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+209.3%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.19B
Shares outstanding, FY2025
Change, 5 years+99.2%
Change, 10 years—
The share count grew 99% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 74.2M
total assets, end of FY2025
Total assetsUSD 74.2M
EquityUSD 38.2M
CashUSD 3.2M
Current ratio1.86×
Equity funds 51% of total assets.
History
10 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue $B
0.0
0.0
0.0
0.0
·
·
·
·
·
·
Operating income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
−0.0
−0.0
−0.0
−0.0
·
·
·
·
−0.0
·
Income tax $B
0.0
·
·
·
·
·
·
·
·
·
Net income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
−0.06
−0.11
−0.14
−0.03
−0.05
−0.05
−0.16
−0.05
−0.05
−0.03
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
ROE %
−46.9
−115.5
−245.1
·
·
·
·
·
·
·
Shares out B
0.19
0.17
0.17
0.13
0.04
0.03
0.02
0.02
0.02
0.02
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
34 of 34
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed